<DOC>
	<DOCNO>NCT00109304</DOCNO>
	<brief_summary>This study do determine safety tolerability new investigational vaccine refer VEE IA/B V3526 , may induce production specific antibody vaccinate human , may protect infection Venezuelan Equine Encephalitis ( VEE ) Virus .</brief_summary>
	<brief_title>Safety , Tolerability Immunogenicity Venezuelan Equine Encephalitis ( VEE ) Attenuated Live-Virus Vaccine</brief_title>
	<detailed_description>Safety Objectives : 1 ) To determine preliminary safety , reactogenicity , tolerability VEE IA/B V3526 VEE-naïve healthy volunteer single dose subcutaneous ( SC ) administration ; 2 ) To evaluate virological safety assess serum viremia viral shed nose throat . Immunogenicity Objectives : 1 ) To assess humoral immune response ( plaque reduction neutralize antibody titer ( PRNT ) ) VEE subtype IA/B SC administration different dose-levels VEE IA/B V3526 vaccine candidate ; 2 ) To assess duration immune response six month VEE IA/B V3526 vaccination base PRNT ; 3 ) To identify two suitable VEE IA/B V3526 vaccine dose-levels future administration dose optimization expand safety study . Exploratory Objectives : 1 ) To collect store serum future development immunogenicity assay ( e.g. , ELISA ) multiple VEE subtypes IA/B , IE , IIIA , possible subtypes ; 2 ) To collect store serum future use development passive transfer challenge model ; 3 ) Collect VEE IA/B V3526 positive serum ( Positive Control Serum ) Day 21 visit .</detailed_description>
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalomyelitis , Equine</mesh_term>
	<mesh_term>Encephalomyelitis , Venezuelan Equine</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>The volunteer male female 18 40 year age ( inclusive ) . The volunteer able willing comply protocol procedure : 2week 15 nights/ ( 14day ) inpatient stay availability followup visit six month post vaccination . The volunteer good health , determine Investigator follow complete medical history physical examination , volunteer clinically significant illness medical history exam ( e.g. , asthma , hypertension ) require hospitalization within six month vaccination study . The volunteer follow laboratory parameter within normal range : *total WBC , *hemoglobin , *platelets , *LFT ( liver function test ( AST , ALT , ALP , bilirubin ) *negative proteinuria . Other laboratory parameter must within 10 % upper low limit normal range Northwest Kinetics clinical laboratory clinically significant assessed Investigator and/or Sponsor Medical Monitor . Female volunteer must pregnant nursing , must nonchildbearing potential ( e.g. , surgically sterilize postmenopausal ) . If volunteer woman childbearing potential ( WCBP ) , must verbalize use acceptable method contraception ( i.e. , hormonal contraception ( injectable oral ) intrauterine device ) abstinence least 30 day 180 day vaccination . The volunteer agree donate blood least six month vaccination . The volunteer successfully complete Test Understanding protocol ( answered 90 % question correctly ) , sign ICF ( inclusive HIPAA authorization ) . The volunteer agree his/her blood sample collect stored future investigation relate VEE vaccine development ( e.g. , assay development ) future VEErelated research study . The volunteer provide Northwest Kinetics Site Subject Instructions participation agree Northwest Kinetics Site Subject Instructions . History exposure VEE , WEE ( Western Equine Encephalitis ) , EEE ( Eastern Equine Encephalitis ) , and/or CHIK ( Chikungunya ) without serological evidence ( PRN ) . History allergic reaction human serum albumin ( HSA ) vaccine component ( i.e. , DMEM ) , history anaphylaxis serious adverse reaction vaccine . History seizure disorder history encephalitic process sequela . Frequent severe headache etiology . Chronic , severe , recurrent joint pain arthritis etiology . History diabetes first degree relative . History gestational diabetes . Abnormal fast blood glucose . Current use antiviral systemic immunomodulatory pharmacotherapy . Use immunosuppressive agent corticosteroid ( i.e. , systemic total dose 20 mg/day 2 mg/kg 20 mg/day , `` burst '' therapy , intranasally administer , inhaled steroid within 3 month prior study ) . Currently enrol investigational protocol participate clinical trial use investigational product within last month . Current plan participation blood donation result blood volume &gt; 450 mL per 8 week period . Vaccination attenuate livevaccine ( e.g. , varicellazoster vaccine ) within 60 day prior testvaccine administration . Vaccination inactivate vaccine ( e.g. , polio hepatitis A vaccine ) within 30 day prior testvaccine administration . Oral temperature &gt; 100.0°F time schedule testvaccine administration . The volunteer clinically significant abnormality ECG . The volunteer body mass index &gt; = 40 kg/m2 great equal 100 lbs ideal body weight . Personal family history multiple sclerosis , immune system stimulation may exacerbate disorder . Signs symptoms illness time schedule testvaccine administration , consider clinically relevant Principal Investigator ( PI , Study Doctor ) . WCBP current plan pregnancy within 30 day schedule testvaccine administration and/or study ( i.e. , Day 0 Day 180 ) . Female volunteer ( WCBP ) pregnant , breastfeeding , test positive pregnancy test time vaccination , unwilling use acceptable method contraception ( i.e. , hormonal contraception ( injectable oral ) intrauterine device ) abstinence within 30 day 180 day study . Positive HIV , HBsAg HCV serology . The volunteer positive result urine drug screen test common substance abuse amphetamine , barbiturate , benzodiazepine , cocaine , opiates , cannabinoids . ( If positive screen , confirmatory test shall perform applicable ) . The volunteer previous diagnosis serious psychiatric disorder . For purpose , serious psychiatric disorder define illness require hospitalization within previous 12 month and/or routine administration one medication control anxiety , mood , sleep disorder ; history suicide attempt . The volunteer consider , reason , Investigator unsuitable candidate receipt investigational treatment . The specific reason exclusion element must completely document screen case report form . The volunteer unwilling comply aspect protocol post vaccination Day 180 ( ±7 day ) assessment , volunteer 's medical psychiatric condition occupational responsibility preclude compliance protocolspecified procedure . The volunteer screen laboratory value total WBC , Hemoglobin , platelet , LFT ( AST , ALT , ALP , Bilirubin ) within normal range and/or positive urine test proteinuria .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Venezuelan Equine Encephalitis</keyword>
	<keyword>VEE</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Provide protective immunity VEE subtypes IA/B</keyword>
</DOC>